Robert J. Hugin - Oct 3, 2022 Form 4/A - restatement Insider Report for Biohaven Ltd. (BHVN)

Role: Director
Signature: /s/ George Clark, Attorney-in-Fact
Stock symbol: BHVN
Transactions as of: Oct 3, 2022
Transactions value $: -$97,193
Form type: 4/A - RESTATEMENT
Date filed: 10/12/2022, 06:31 PM
Date Of Original Report: Oct 5, 2022
Previous filing: Sep 30, 2022
Next filing: May 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Ownership	Footnotes
transaction	BHVN	Common Shares	Tax liability	-$97.2 K	-13 K	-50%	$7.50	13 K	Oct 3, 2022	Direct	F1, F2

Explanation of Responses:

Id	Content
F1	These shares were withheld by the Issuer in connection with share settlement to cover the cost of the stock options.
F2	This amendment is being filed to correct the amount of shares beneficially owned reported in the Form 4 filed on October 5, 2022 (the "Original Form 4"). The Original Form 4 inadvertently incorrectly reported that 3,263 shares were withheld by the Issuer in connection with the share settlement to cover the cost of the stock options; however, as reflected in this amendment, 9,790 shares were withheld by the Issuer in connect with the share settlement to cover the cost of the stock options. There were no other changes made to the information in the Original Form 4.

Content

These shares were withheld by the Issuer in connection with share settlement to cover the cost of the stock options.

This amendment is being filed to correct the amount of shares beneficially owned reported in the Form 4 filed on October 5, 2022 (the "Original Form 4"). The Original Form 4 inadvertently incorrectly reported that 3,263 shares were withheld by the Issuer in connection with the share settlement to cover the cost of the stock options; however, as reflected in this amendment, 9,790 shares were withheld by the Issuer in connect with the share settlement to cover the cost of the stock options. There were no other changes made to the information in the Original Form 4.